P2.40: CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients von Hernandez, Maurenis, Ortiz, Ramon A., Neninger, Elia, Amador, Rosa M., Cala, Mireisy, Camacho, Kirenia, Salomon, Eva, Guerra, Pedro P., Mendoza, Ivis, Sanchez, Carlos, Viada, Carmen, Gonzalez, Matilde, Torres, Lourdes T., Fonseca, Vivian, Garcia, Ivon, Bello, Loisel, Alonso, Maribel, Rodriguez, Maria C., Cruz, Aivin, Valdes, Rolando, Lorenzo, Geidy, Cepeda, Meylan, Saumel, Yaimarelis, Crombet, Tania

Volltext

P2.40: CIMAvaxEGF Vaccine for the Treatment of Real-World NSCLC Patients: Track: Immunotherapy von Hernandez, Maurenis, Ortiz, Ramon A., Neninger, Elia, Amador, Rosa M., Cala, Mireisy, Camacho, Kirenia, Salomon, Eva, Guerra, Pedro P., Mendoza, Ivis, Sanchez, Carlos, Viada, Carmen, Gonzalez, Matilde, Torres, Lourdes T., Fonseca, Vivian, Garcia, Ivon, Bello, Loisel, Alonso, Maribel, Rodriguez, Maria C., Cruz, Aivin, Valdes, Rolando, Lorenzo, Geidy, Cepeda, Meylan, Saumel, Yaimarelis, Crombet, Tania

Volltext